Marcy S. Klevorn - 31 Dec 2025 Form 4 Insider Report for HUMANA INC (HUM)

Reporting relationship: Director
Issuer ticker: HUM
Reported as of: 31 Dec 2025
Net transaction value: +$7,248
SEC form: 4
Accepted by SEC: 05 Jan 2026, 13:47:58 UTC
Prior SEC filing: 02 Oct 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: Marcy S. Klevorn

Key filing fact

Marcy S. Klevorn filed Form 4 for HUMANA INC (HUM) on 05 Jan 2026.

Key facts

This page summarizes Marcy S. Klevorn's Form 4 filing for HUMANA INC (HUM).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Jan 2026, 13:47.

Change

Previous filing in this sequence was filed on 02 Oct 2025.
Current net transaction value: +$7,248.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001692367 Primary reporting owner

Klevorn Marcy S

Relationship: Director
Address: HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
Signature: Marcy S. Klevorn
Signature date: 05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 436
Date: 31 Dec 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +766
Change %: +38%
Price: $0.000000
Shares after: 2,771
Date: 02 Jan 2026
Ownership: Direct
Underlying class: Humana Common
Underlying amount: 766
Exercise price
Footnotes: F1

HUM transaction Derivative

Restricted Stock Units

Award

Transaction value: $7,248
Shares: +28
Change %: +112%
Price: $258.87
Shares after: 53
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Humana Common
Underlying amount: 28
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Footnote F2

Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).